Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 6, 2017 – Flexion Therapeutics announced the FDA approval of Zilretta (triamcinolone acetonide) extended-release injection, for the management of osteoarthritis (OA) pain of the knee.
Return to publications